✦ LIBER ✦

900 OPEN-LABEL PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF PERSONALIZED PEPTIDE VACCINATION (PPV) IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER(CRPC)

✍ Scribed by Noguchi, Masanori; Moriya, Fukuko; Suekane, Shigetaka; Matsuoka, Kei; Arai, Gaku; Matsueda, Satoko; Sasada, Tetsurou; Yamada, Akira; Itoh, Kyogo

Book ID: 123005503
Publisher: Lippincott Williams and Wilkins
Year: 2011
Tongue: English
Weight: 54 KB
Volume: 185
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2011.02.2609

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of personalized peptide v

Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy

✍ Masanori Noguchi; Fukuko Moriya; Shigetaka Suekane; Kei Matsuoka; Gaku Arai; Sat 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB

Safety and efficacy of sorafenib in pati

Safety and efficacy of sorafenib in patients with castrate resistant prostate cancer: A Phase II study

✍ Mohammad Reza Safarinejad 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 178 KB

Once-daily Dasatinib: Expansion of Phase

Once-daily Dasatinib: Expansion of Phase II Study Evaluating Safety and Efficacy of Dasatinib in Patients With Metastatic Castration-resistant Prostate Cancer

✍ Evan Y. Yu; Christophe Massard; Mitchell E. Gross; Michael A. Carducci; Stephane 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 480 KB

A phase II open label trial evaluating s

A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma

✍ Tim F Greten; Alejandro Forner; Firouzeh Korangy; Gisele N'Kontchou; Nathalie Ba 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 790 KB

215 A PHASE II OPEN LABEL TRIAL EVALUATI

215 A PHASE II OPEN LABEL TRIAL EVALUATING SAFETY AND EFFICACY OF A TELOMERASE PEPTIDE VACCINATION IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA

✍ T.F. Greten; A. Forner; F. Korangy; G. N'Kontchou; N. Barget; C. Ayuso; L. Orman 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

P124 Long-term safety of radium-223 dich

P124 Long-term safety of radium-223 dichloride (Ra-223) in patients with castration-resistant prostate cancer (CRPC) and bone metastases from the phase 3 ALSYMPCA study

✍ Nilsson, S; Schrader, A.J.; Kliment, J.; Solberg, A.; Franzén, L.; Bottomley, D. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 66 KB